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Purpose: The purpose of this study was to review the results ofpercutaneous transluminal 
renal artery angioplasty (PTRA) in patients with atherosclerosis to assess afety, anatomic 
and functional outcome, and differences in outcome between ostial and nonostial lesions. 
Methods: We used retrospective review of 52 consecutive patients who had undergone 
attempted PTRA for renal artery atherosclerosis during the calendar years 1987 to 1992. 
Results: Fifty-two patients had 60 renal arteries on whom PTRA was attempted. The mean 
age was 68 years. Atherosclerosis was generalized in 81% of the patients. The indication 
for angioplasty was salvage of fimctioning renal parenchyma in 81% of patients. Eight 
patients were undergoing dialysis at the time of attempted PTRA. Five arteries (8%) could 
not be dilated. There were one cardiac death and two arterial complications requiring 
surgery within 30 days. Thirty-five percent of patients with available angiograms had an 
anatomic improvement above a threshold of one stenotic group (30% to 40% diameter 
improvement), with residual stenosis of less than 50%. Half of patients treated for 
hypertension had improvement in their hypertension. Overall, there was no change in 
creatinine l vels before and after the procedure. Four of eight patients undergoing dialysis 
at the time of PTRA were able to discontinue dialysis during follow-up. Four patients 
(11%) required surgical bypass and five patients (14%) required chronic dialysis during 
follow-up. 
Conclusions: Modest success at low risk can be expected from PTRA in a group of patients 
with severe atherosclerosis. No significant difference in results between ostial and 
nonostial lesions was noted. (J VASC SURG 1995;21:909-15.) 
Early experience with percutaneous transluminal 
renal artery angioplasty (PTRA) in patients with 
atherosclerosis was primarily for treatment of reno- 
vascular hypertension. Atherosclerotic lesions of the 
renal artery were divided into two categories: ostial 
and nonostial) ,20st ia l  lesions were judged to 
impinge on the renal arery lumen by an aortic plaque. 
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Early experience with ostial lesions observed poor 
anatomic and fimctional results from PTRA. Ath- 
erosclerotic lesions that were not at the ostium 
(although still characteristically in the proximal renal 
artery) were found to have a higher rate of anatomic 
success and a longer durability of anatomic and 
functional improvement. 1-3
In our own institution, two changes have oc- 
curred in the patients with atherosclerosis coming to 
intervention for renal artery stenosis. First, as a group 
the atherosclerosis is more severe and diffuse. Inter- 
vention is more likely to be performed primarily for 
preservation of renal function than exclusively for 
management of hypertension. 4 Second, PTRA, be- 
cause of its apparent safety and low risk, has been 
applied more liberally to these patients with far- 
advanced atherosclerosisl We report our recent ex- 
perience with PTRA in a consecutive series of 
patients with atherosclerosis. Our goal is to assess in 
this group of patients with severe atherosclerosis 
safety of the procedure, anatomic and functional 
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Table I. Stenosis cores 





outcome of intervention, and, in particular, to 
identify differences in outcome between ostial and 
nonostial atherosclerotic lesions. 
METHODS 
Fifty-two consecutive patients underwent at- 
tempted PTRA for renal artery atherosclerosis during 
the calendar years 1987 to 1992 and form the basis 
for this report. Patients' names were obtained from 
the interventional radiology log; follow-up was by 
review of records and phone conversations with 
patients and referring physicians. Atherosclerosis was 
categorized as local if the only clinical manifestation 
was the renal artery stenosis. If there were clinical 
consequences of atherosclerosis in other organ sys- 
tems, the atherosclerosis was categorized as general- 
ized) PTRA was considered to have been performed 
primarily for salvage of renal parenchyma if the 
intervention was for stenosis in the artery to a single 
functioning lddney, if there was bilateral stenosis 
greater than 75% in diameter, or if there was greater 
than 75% stenosis of a single renal artery with an 
elevated creatinine level. 4 
Anatomic results of PTRA were judged by 
blinded review of available arteriograms (conven- 
tional films and digital subtraction angiography) by 
four independent observers (two interventional ra- 
diologists and two vascular surgeons). The degree of 
stenosis of the renal artery was assessed as percent 
diameter and placed into one of four categories on the 
basis of severity (Table I). Diameter of stenosis was 
calculated as 1 minus the luminal diameter at the 
stenosis divided by the lumen of the uninvolved renal 
artery distal to the stenosis. After scoring, the results 
were unblinded and the degree of change was 
assessed by comparing the average pre-PTRA and 
post-PTRA scores. For subsequent analysis, we chose 
to consider an improved stenosis as one that was 
reduced by at least one stenotic category with a 
residual stenosis of 50% or less. Arteries that showed 
less improvement, worsened condition, or could not 
be dilated were considered unimproved. 
At the same time, arteriograms were judged by 
the same four observers to show an ostial or nonostial 
lesion. Where three or four observers concurred on 
one of these categories, the lesion was so categorized. 
If two observers believed the lesion was ostial and 
two believed it was nonostial, the lesion was catego- 
rized as indeterminate. 
The functional results of PTRA on hypertension 
were initially categorized as cured, improved, un- 
changed, or worse. Cured included patients who 
became normotensive after stopping all antihyper- 
tensive medication. Patients were considered to be 
improved when antihypertensive medication could 
be reduced and blood pressure remained stable or 
improved. Patients who continued to require the 
same or increased antihypertensive medication were 
considered to be unchanged or worse. Because of 
small numbers in each category, we subsequently 
categorized results of hypertension simply as im- 
proved (the cured and improved groups) or unim- 
proved (the unchanged or worse groups). 
Results of PTRA on renal function were assessed 
by comparing preintervention serum creatinine l vels 
with early (<30 days) postprocedure creatinine 
levels. We also looked specifically at patients under- 
going dialysis at the time of PTRA to see how many 
discontinued ialysis and remained so. We also 
identified patients who had discontinued ialysis 
after the procedure who underwent dialysis during 
follow-up. Finally, we looked for patients who 
required repeat PTRA or reconstructive surgery. 
Statistical comparison of preprocedure and postpro- 
cedure results was made by a paired Student test. 
RESULTS 
The 52 patients had a total of 60 renal arteries on 
which PTRA was attempted. Eight patients under- 
went bilateral procedures. The mean age was 68 years 
(range 30 to 83 years). Atherosclerosis was general- 
ized in 81% of these patients (Table II), with one 
third of the patients having undergone prior coro- 
nary artery bypass or coronary angioplasty. The 
indication for PTRA was salvage of functioning renal 
parenchyma in 81% of patients (Table III). Twenty- 
one patients underwent PTRA of the artery to a 
single functioning kidney. Eight of these 52 patients 
were already undergoing dialysis at the time of 
attempted PTRA. 
In five arteries in four patients he guide wire or 
catheter could not be passed; thus PTRA could not 
be performed. These are not included as arteries with 
completed angioplasty but are included in the ana- 
tomic and functional results as unsuccessful dilations 
or unimproved anatomic result. The angiograms of 
four patients were not available for review. Each of 
these patients underwent a completed ilation of one 
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Table II. Extent of atherosclerosis 
(n = 52 patients) 
Category No. % 
Local 10 19 
Generalized 42 81 
Coronary 28 54 
Cerebrovascular i 1 2 I 
Lower extremity 18 35 
Table III. Indications for attempted 
angioplasties (n = 52 patients) 
Indications No. % 
Hypertension 10 19 
Total salvage 42 81 
Bilateral stenosis > 75% 8 16 
Stenosis to single kidney 23 44 
> 75% stenosis with creatinine > 1.8 mg/dl 11 21 
renal artery. They are included in the overall results, 
but because we could not independently define the 
location of the lesion or the severity of the stenosis, 
these four arteries are excluded from analysis of 
anatomic results. Eleven patients were lost to 
follow-up after hospital discharge and are not in- 
cluded in the analysis of long-term outcome. 
There was one death within 30 days of PTRA 
(patient mortality rate of 2%). Two other major com- 
plications in 60 arteries (3%) included apseudoaneu- 
rysm after successful angioplasty hat required opera- 
tive repair and one patient with an unsuccessful 
PTRA whose renal artery thrombosed uring the 
attempt, requiring nephrectomy. This patient was 
undergoing dialysis before the procedure and contin- 
ued to undergo long-term dialysis after the proce- 
dure. The average follow-up was 2.3 years. One early 
and eight late deaths yielded amortality rate of 18% 
at a mean of 2.3 years. Four patients died of compli- 
cations of coronary atherosclerosis, three of cancer, 
one of kidney failure, and one of unknown causes. 
Table IV details preprocednre and postprocedure 
stenosis cores in the group in which dilation could 
be completed and relates them to anatomic location 
of the stenosis. With completed dilation, patients on 
average improved a little greater than one category 
and there was no statistical difference between ostial, 
nonostial, and indeterminate lesions. 
Forty-two percent of dilated arteries with nonos- 
tial lesions showed anatomic mprovement (improve- 
ment -> 1 stcnotic ategory with a residual stenosis 
< 50%) compared with 29% with ostial esions and 
22% with indeterminate l sions. There were no 
statistically significant differences between these 
groups, which may be due to sample size. Of the five 
arteries that could not be dilated, three had nonostial 
lesions, two were indeterminate, and none was 
categorized as ostial. 
Overall, 36% of patients had cured or improved 
blood pressure response after PTRA. Of the 10 
patients in whom the indication for PTRA was 
control of hypertension, half were cured or im- 
proved and half were unimproved by the procedure. 
Fifty-four percent of patients "with improved ana- 
tomic results also had improvement in blood 
pressure. 
The mean creatinine level of all patients not 
undergoing dialysis before the procedure was 2.90 
mg/dl and after the procedure it was 2.6i mg/dl 
(difference not significant). Because patients with 
bilateral renal artery stenosis had mixed combinations 
of lesions, we looked at preprocedure and postpro- 
cedure creatinine levels in patients with unilateral 
renal artery stenosis to relate change in renal function 
to location of stenosis. No significant difference was 
noted in the pre-PTRA and post-PTRA creatinine 
level between ostial, nonostial, and indeterminate 
lesions (Table V). There was no difference in 
postprocedure creatinine l vels between the anatomi- 
cally improved and unimproved groups. There was 
no difference in the functional outcome of the eight 
patients who had bilateral renal artery stenosis treated 
with PTRA. 
Four of eight patients who were undergoing 
dialysis before the procedure were able to be removed 
from dialysis after the procedure. None of the four 
patients required ialysis for the duration of follow- 
up. Two of three patients with ostial esions could be 
removed from dialysis, as could the single patient 
with an indeterminate l sion. One patient who 
discontinued dialysis after the procedure could not be 
categorized because angiograms were not available 
for review. None of the three patients with nonostial 
lesions could be removed from dialysis. 
We looked at the need for surgical reconstruction 
or long-term dialysis during an average follow-up of 
2.3 years after the procedure in 37 patients who had 
undergone a complete PTRA. Excluded were 11 pa- 
tients lost to follow-up and four patients who were 
undergoing dialysis before the procedure and who 
continued with dialysis after PTRA. Five patients 
(14%) not undergoing hemodialysis after PTRA did 
undergo dialysis during follow-up. This represents 
16% of the patients who underwent salvage proce- 
dures who were available for follow-up. Four patients 
(11%) required surgical bypass for restenosis during 
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Table IV. Anatomic results: mean stenosis cores of arteries with successful PTRA 
(n = 51 in 48 patients) ~
Before Aj~er Average zl p Value No. of arteries 
Ostial 3.54 2.40 1.14 0.007 14 
Nonostial 3.20 1.90 1.30 0.001 31 
Indeterminate 3.67 2.50 1.17 0.012 6 
Totals 3.44 2.22 1.19 < 0.001 51 
~Excludes five arteries in four patients in whom the wire or catheter could not be passed and four arteries in four patients whose 
artcriograms were not available for review. 
Table V. Correlation of functional results with anatomic results: comparison of location of lesion 
with creatinine values ~ 
Mean pre-Cr level Mean post-Cr level 
(mg/dl) (mg/dl) p Value 
Ostial (n = 7) 2.23 2.29 NS 
Nonostial (n = 17) 2.09 1.93 NS 
Indeterminate (n = 4) 1.93 1.93 N__fiS 
Totals (n = 28) 2.08 2.05 NS 
Cr, Creatinine; NS, not significant. 
~Includes all patients with successful angioplasties not undergoing dialysis before the procedure; excludes patients with bilateral stenosis 
or incomplete data. 
follow-up. One patient underwent repeat PTRA 
without other intervention. The need for bypass or 
dialysis during follow-up did not correlate with ana- 
tomic location of the lesion or whether the lesion was 
categorized as anatomically improved or unim- 
proved. 
DISCUSSION 
Management decisions regarding renal artery 
stenosis at this institution are generally made con- 
jointly by members of the vascular surgery, interven- 
tional radiology, and nephrology services. Initially, 
PTRA in our institution was applied to a highly 
selective group of patients, primarily those with 
fibromuscular disease and nonostial atherosclerotic 
lesions. During the study interval, PTRA began to be 
applied more liberally to patients with atherosclerotic 
lesions, including those with ostial lesions. Thus the 
population of patients coming to PTRA during this 
recent interval is characterized almost exclusively by 
patients with atherosclerosis (only four patients with 
fibromuscular disease underwent dilatation during 
this interval). The atherosclerosis was generalized in 
more than 80% of the patients and, for more than 
80% of the patients, the indication for intervention 
was primarily preservation of functioning renal 
parenchyma rather than management of hyperten- 
sion. The mean age of 68 years is old compared with 
earlier studies. 1,2 Forty-four percent of the patients 
underwent dilation of a critical lesion in an artery to 
a single functioning kidney and 15% of the patients 
were undergoing dialysis at the time of PTRA. These 
characteristics describe agroup of patients with more 
severe and more advanced atherosclerosis than was 
present in most earlier studies in which PTRA was 
done primarily for management of hypertension. 13
These characteristics are similar or worse in severity 
to those of a group of surgical patients treated 
between 1985 and 1990 that we reporte d recently. 4 
Our experience shows that PTRA can be per- 
formed in this group of patients with advanced 
atherosclerosis with relative safety. The physiologic 
stress (particularly cardiac) of PTRA is substantially 
less than that of surgery, assuming no complication 
and a successful result. The one death 4 weeks after 
PTRA was not procedure related. Both the rate of 
inability to dilate (8%) and the two complications 
requiring surgery in 60 arteries (3%) compare 
favorably with other reports in patients with severe 
atherosclerosis.2,68 
Anatomic success by our criteria is modest. The 
group improved an average of a little greater than one 
stenotic score or about 30% to 40% diameter im- 
provement. However, if we set a threshold of im- 
provement of one category or more with a residual 
stenosis of less than 50% diameter, only 35% had a 
good anatomic result. In contrast o some other re- 
ports, we have included in the denominator of this 
calculation patients in whom PTRA was attempted 
but could not be completed. We do this in light of our 
own experience inwhich one of our two arterial com- 
plications was in the category of attempted but not 
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completed PTRA and resulted in a nephrectomy for 
renal infarction. This limited anatomic improvement 
after PTRA, when quantitatively reviewed in blinded 
fashion by multiple independent observers, contrasts 
with reports written at the time of PTRA that tended 
to be qualitative and somewhat optimistic. 
The frequency of anatomic improvement in 
nonostial esions was slightly greater than that of 
ostial lesions (42% to 29%; difference not signifi- 
cant). In our judgment, however, this difference in 
outcome between the two anatomic ategories is not 
sufficient to determine by itself whether enal artery 
angioplasty should be attempted. 
During the period of this study, PTRA was not 
attempted in all patients with renal artery atheroscle- 
rosis. An approximately equal number of patients 
underwent operative renal artery revascularization. 
The indications for operation were most frequently 
(1) failed PTRA or recurrent stenosis after PTRA 
(performed at our institution or elsewhere) or (2) the 
need for concomitant aortic reconstruction. In addi- 
tion, in a small number of patients urgery was not 
attempted because of either inappropriate r nal artery 
anatomy (e.g., occlusion or severely eccentric plaque) 
or severe aortoiliac atherosclerotic or aneurysmal 
disease that was judged to have a high risk of 
atheroembolization. 
The incidence of functional improvement in 
blood pressure in the group that underwent PTRA 
was low. Three patients who were normotensive 
without medication and 17 whose conditions im- 
proved represent 38% of the population. When 
PTRA was performed primarily for hypertension, 
50% of patients benefitted from the procedure. The 
50% whose conditions did not improve includes 
12% technical failures. These results compare with an 
average of 70% of patients whose conditions were 
cured or improved by PTRA as summarized recently 
from 10 large published series. 9 Patients with nonos- 
tial lesions in our series had a slightly better chance of 
improvement in their hypertension than had patients 
with ostial or indeterminate l sions, but with small 
numbers this was not a statistically significant differ- 
ence. These overall disappointing results in the 
management of hypertension reflect a group of 
patients with advanced atherosclerosis in whom 
salvage of renal parenchyma was more often the 
indication for intervention than management of 
hypertension itself. It also reflects a lack of prepro- 
cedure functional studies even in those done for 
hypertension, with no patient undergoing split renal 
vein renin studies and only rare patients undergoing 
captopril-stimulation studies. 1° 
The impact of PTRA on renal function is difficult 
to judge in the group as a whole. There were no 
differences between preprocedure serum creatinine 
and serum creatinine l vels in the early postprocedure 
interval. These results are similar to those we have 
found in our surgical series, 4 and they support our 
notion that in most of these patients with advanced 
atherosclerosis the goal is maintenance of renal 
function, not improvement. These results are also 
similar to those of a recent randomized study of both 
surgical patients and those undergoing PTRA that 
showed no statistically significant change in creati- 
nine levels before and after intervention and in whom 
only 17% of patients undergoing PTRA had im- 
proved serum creatinine levels, n There were no 
differences in the overall resuks of serum creatinine 
levels between ostial and nonostial lesions. 
One subgroup had evidence of improvement in
renal function. These are the four out of eight 
patients undergoing dialysis who were able to 
discontinue dialysis after PTRA. All four patients 
were not undergoing dialysis during follow-up. The 
location of the atherosclerotic lesion in the ostium or 
the renal artery did not influence whether the patient 
was able to discontinue dialysis after PTRA or the 
requirement for dialysis during follow-up after 
PTRA. Only patients who had recent deterioration of
renal function that required ialysis were considered 
for PTRA. In general, we do not consider patients 
undergoing chronic long-term dialysis candidates for 
either surgical or angioplastic ntervention# 
That 16% of patients undergoing procedures for 
salvage required dialysis in 2.3 years is difficult to 
distinguish from "natural history" studies. Although 
earlier reports indicated that 39% of arteries with 
greater than 75% stenosis progress to complete oc- 
clusion during an average follow-up of 13 months, 12 
later reports  13,14 indicate that the risk of occlusion 
may be less. Noninvasive studies that use duplex ul- 
trasonography suggest hat with lesions of greater 
than 60%, the occlusion rate is on the order of 5% to 
6% per year, 14 not  dissimilar from the need for dialy- 
sis in our own group. Close analysis here is difficult 
considering the different populations, and recogniz- 
ing the need for dialysis in follow-up does not neces- 
sarily represent failure of the reconstruction. 4 
Four patients had recurrent stenosis eventually 
requiring surgical reconstruction. Four patients were 
unable to undergo dilation and five patients under- 
went dialysis. Thus 25% of the entire group had 
either inability to dilate or anatomic failure requiring 
surgery or required ialysis during follow-up. 
Our conclusion from these data is that in a group 
of patients with severe atherosclerosis modest im- 
provement can be expected from PTRA with low 
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risk. We were able to detect no differences in 
outcome between patients with ostial and those with 
nonostial lesions. PTRA is used best in patients who 
are not good operative candidates. Operative revas- 
cularization is recommended in patients who are at 
appropriate risk who independently require con- 
comitant aortic reconstruction or who cannot be 
treated successfully with PTRA. Ostial location of an 
atherosclerotic lesion alone should not be considered 
a contraindication to attempted PTRA. PTRA in 
atherosclerosis, however, is subjec t to restenosis. 
With modest results, continued close follow-up is 
essential and repeat PTRA or surgical reconstruction 
may be needed, as has been emphasized by others. 11 
We thank Ms. Leslie Couper for help with statistical 
analysis and Ms. Tracey Rowe for manuscript preparation. 
REFERENCES 
1. Cicuto KP, McLean GK, Oleaga JA, Freiman DB, Grossman 
RA, Ring EJ. Renal artery stenosis: anatomic classifcation for 
percutaneous transluminal angioplasty. Am J Radiol 1981; 
137:599-601. 
2. Sos TA, Picketing TG, Sniderman K, et al. Percutaneous 
transhiminal renal angioplasty in renovascular hypertension 
due to atheroma or fibromuscular dysplasia. N Engl J Med 
1983;309:274-9. 
3. Novick AC. Percutaneous transluminal angioplasty and sur-
gery of the renal artery. Eur J Vasc Surg 1994;8:1-9. 
4. Bredenberg CE, Sampson LN, Ray RS, Cormier RA, Heintz 
S, Eldrup-Jorgensen J. Changing patterns i  surgery for 
chronic renal artery occlusive diseases. J VASC SURG 1992; 
15:1018-24. 
5. Ernst CB, Stanley JC, Marshall FF, Fry WJ. Renal revascu- 
larization for arteriosclerotic renovascutar hypertension: prog- 
nostic implications of focal renal arterial vs. overt generalized 
arteriosclerosis. Surgery 1977;73:859-67. 
6. Martin LG, Casarella WJ, Gaylord GM. Azotemia caused by 
renal artery stenosis: treatment by percutaneous angioplasty. 
Am J Radiol 1988;150:839-44. 
7. Kim PK, Spriggs DW, Rutecki GW, Reaven RE, Blend D, 
Whittier FC. Transluminal angioplasty in patients with 
bilateral renal rtery stenosis or renal artery stenosis in a 
solitary functioning kidney. Am J Radiol 1989; 153:1305 -8. 
8. Sos TA. Angioplasty for the treatment of azotemia and 
renovascular hypertension in atherosclerotic renal artery 
disease. Circulation 1991;83(suppl):l162-6. 
9. Ramsay LE, Waller PC. Blood pressure response to percuta- 
neous transluminal angioplasty for renovascular hypertension: 
an overview of published series. Br Med J 1990;300:569-72. 
10. Meier GH, Sumpio B, Setaro JF, Black HR, Gusberg RJ. 
Captopril renal scintigraphy: a new standard for predicting 
outcome after renal revascularization. J VASC S~:RG1993;17: 
280-7. 
11. Weibull H, Bergqvist D, Bergentz S-E, Jonsson K, Hulthdn 
L, Manhem P. Percutaneous translurninal renal angioplasty 
versus surgical reconstruction of atherosclerotic renal artery 
stenosis: a prospective randomized study. J VASC SUinG 
1993;18:841-52. 
12. Schreiber MJ, Pohl MA, Novick AC. The natural history of 
atherosclerotic and fibrous renal artery disease. Urol Clin 
North Am 1984;11:383-92. 
13. Tollefson DFJ, Ernst CB. Natural history of atherosclerotic 
renal artery stenosis associated with aortic disease. ~ VASC 
SURG 1991;14:327-31. 
14. Zierler RE, Bergelin RO, Isaacson JA, Strandness DE. 
Natural history of atherosclerotic renal artery stenosis: a 
prospective study with duplex ukrasonography. J VASC SURG
1994;19:250-8. 
Submitted Oct. 6, 1994; accepted Jan. 9, 1995. 
D ISCUSSION 
Dr. Richard Gusberg (New Haven, Conn.). You have 
had a long-standing interest in renovascular disease. Several 
years ago before this Society you made a thoughtful and 
provocative presentation emphasizing the changing pat- 
terns and new approaches to elderly patients with diffuse 
atherosclerosis, refractory hypertension, and kidney failure. 
In fact, in the last decade with much of the work done by 
members of this Society there have been significant 
advances in the operative management of patients with 
renovascular disease: improved selection criteria, better 
operative results with expected operative mortality rates 
under 2%, refined operative options with increasing use of 
extraanatomic approaches in patients with diffuse and 
severe atherosclerosis, mprovement in blood pressure of 
80% to 90% anticipated in appropriately selected patients 
who have undergone revascularization, improved or stabi- 
lized renal function in most patients, and outcomes that are 
excellent and durable. Even with concomitant aortic 
replacement as we presented here last year, you can 
anticipate that the operations can be done safely, and at 
least in our group there appeared to be little adverse ffect 
on quality of life and fimctional evels in these elderly 
patients with atherosclerosis. Later in this program from 
the Fallon Clinic in Worcester, the Massachusetts General 
Hospital, and the Brigham & Women's Hospital, sizable 
series of these sick, elderly patients operated on are 
presented with excellent and durable results. 
As technology has advanced, angioplasty has become 
an option in some patients, but the results are mixed. It is 
clearly an alternative in some, it does not work in some, and 
it is not feasible in some patients. The outcomes are short 
term. There are a few studies with long-term durable 
results, and ostial esions in most series present and result 
in results inferior to those with nonostial lesions. 
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With this background, this study asks the question, 
should angioplasty be the initial treatment for all patients 
with clinically significant renal artery stenosis ? They say yes, 
or at least they said yes in the abstract. They seem to not 
quite say yes in the presentation. I believe their data are 
unconvincing. This is a retrospective valuation of 52 
patients een during 5 years, who are 68 years old with 
expected comorbidity. Of the 52 patients, 41 were available 
for follow-up, which averaged 2 years. There was one death 
and two complications requiring surgery, one of those 
patients requiring a nephrectomy. They defined postdila- 
tion improvement as a residuals tenosis of less than 50%. 
With these criteria in nonostial esions, only 42% of 
patients were improved and in the ostial lesions only 29% 
were improved. A sizable percentage of these patients had 
unimpressive anatomic improvement after an attempt at 
dilation. In this group there was only a 36% overall 
improvement in blood presure control, although five of 10 
patients who were treated primarily for hypertension alone 
had improvement. Functional levels were chafiged before 
and after the procedure, although four of eight patients 
undergoing dialysis had improvement. 
These results are inferior to the current standards that 
we see following large series of patients operated on for 
renovascular p oblems, and in fact they are inferior to the 
results presented by this group before this Society several 
years ago in a series of 69 patients operated on with diffuse 
atherosclerosis. In that series of patients operated on with 
only renal artery lesions there were no deaths, more than 
half the patients had improved blood pressure control, and 
55 % of the patients had improved renal function in the first 
month, although the results were not consistently durable. 
Could you comment on the large number of anatomic 
failures? It seems from the literature and it makes intuitive 
sense that clinical benefit should follow anatomic improve- 
ment. Many of these patients did not undergo good 
revascularization; is that the reason the results were mixed? 
What about stents in the patients with ostial esions? There 
has been increased interest in the use of stents, particularly 
for ostial stenoses. Did any of these patients have stents for 
their ostial lesions? 
Second, do you have any sense of what the durability 
of these procedures i ? Was there any follow-up with these? 
A series by Pamlas recently reported on a group of patients 
undergoing angioplasty. In patients with residual stenoses 
of 15% or greater, within 6 months all the patients had a 
residual stenosis of greater than 50%. 
Third, what are your criteria for selecting patients for 
salvage? Do you have any sense as to which patients within 
their expected lifetimes are going to end up undergoing 
dialysis? How did you choose these patients? 
Last, at the Yale Vascular Center we are using a 
selective approach whereby we have vascular surgeons, 
interventional radiologists, and nephrologists using renal 
scintigraphy as a selection criterion. We have found that 
our results are xcellent and consistent. Of the last 100 
patients who have undergone revascularization, about 35 
have been done by angioplasty and the remainder by 
surgery. In the past this group has recommended that type 
of selective approach, and it seems that your attitude has 
changed. Is that a reflection of conviction or just a reflection 
of changing practice and referral patterns? 
Dr. Jens Eldrup-Jorgensen. I would like to address 
the last question first: whether there was a change in 
attitude or our practice pattern toward these patients. To 
that I would say yes. I think that as our experience with 
percutaneous transluminal renal artery angioplasty has 
evolved, we have been more aggressive, and our radiologist 
and especially nephrologists have been willing to offer this 
as an initial treatment to more patients. In addition, we are 
willing to offer it to an elderly, frail group of patients with 
more advanced atherosclerosis who would not be consid- 
ered operative candidates otherwise. I think to compare this 
to our surgical series is not entirely fair. I think this is a 
group of patients who do have evidence of more advanced 
disease. 
The first question was in regard to a large number of 
anatomic failures. First, I would emphasize that we 
included in our outcomes patients who were unable to 
undergo dilation in whom we could not pass the guide wire 
or the catheter, so these patients were included in the 
outcomes. They are oftentimes excluded in angioplasty 
series. In terms of the evaluation of the dilation, frequently 
at the time the procedure was performed by the interven- 
tional radiologist, it was described in cosmetic terms such 
as an improved appearance; I think when we looked at 
those blinded studies there was a little more critical or 
honest evaluation and there was less of a propensity to 
attribute a narrowing to an intimal flap that would heal 
with time. We did find that there was a significant number 
of patients who did not have a good anatomic outcome; 
again we would attribute this to the fact that we were trying 
to dilate in patients with large ~:ed perirenal plaques that 
were oftentimes calcified. 
The second question was with regard to stents. During 
the period of the study, we were not using stents very 
much. As a matter of fact none of the patients in this series 
had stents. 
The next question was related to the durability of the 
procedure itself in terms of long-term follow-up. As you are 
well aware, anatomic outcome does not always correlate 
with functional outcome, and because routine angiography 
was not performed on these patients during follow-up, I
cannot address that question exactly. 
Relating to the next question, we do know that 14% of 
these patients went on to require dialysis during the period 
of follow-up, which averaged 2 years, and in some of those 
patients there was still a patent renal artery. 
